Stress Reduction Intervention for Racism-Related Stress
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a stress reduction program to determine its effectiveness in improving well-being and reducing inflammation in African American women at risk for heart or metabolic diseases. Participants will join one of two groups: one will participate in the Resilience, Stress, and Ethnicity program (RiSE), which focuses on managing stress related to racism, while the other will receive general health education through the Health Education Program (HEP). The trial includes regular online sessions and health measurements such as blood pressure and saliva tests. Post-menopausal women with risk factors like high blood pressure or a history of Type 2 diabetes may be well-suited for this trial. As an unphased trial, this study provides a unique opportunity to contribute to research that could enhance health outcomes for African American women.
Will I have to stop taking my current medications?
The trial does not specify whether you need to stop taking your current medications. However, if you are using immune-altering medications like glucocorticoids, you may not be eligible to participate.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that the Resilience, Stress, and Ethnicity (RiSE) program is safe and well-received. Participants have experienced positive results without major side effects. Studies have found that they reported improved ways of handling stress, particularly stress related to racism.
The RiSE program helps individuals understand and manage stress using generally safe techniques. Participants learn to share and process their experiences with race-related stress, receive information on how racism can affect the body, and develop skills to feel more empowered.
Overall, past studies suggest that the RiSE program is a safe choice for those seeking to reduce stress and improve well-being.12345Why are researchers excited about this trial?
Researchers are excited about the RiSE program because it takes a unique approach to addressing racism-related stress by focusing on resilience and empowerment. Unlike typical stress management options, which might include general cognitive-behavioral therapy (CBT) or mindfulness techniques, RiSE specifically targets the biopsychosocial impacts of racism. This program not only helps individuals process and share their experiences but also provides psychoeducation and skill-building tailored to racial identity development. The combination of these elements aims to empower participants and foster a supportive community, setting it apart from more generic stress reduction methods.
What evidence suggests that this trial's treatments could be effective for reducing racism-related stress?
Research has shown that the Resilience, Stress, and Ethnicity (RiSE) program, an intervention in this trial, can help reduce stress related to racism among African American women. Studies have found that this program may enhance well-being by teaching skills to cope with the negative effects of racism. For instance, previous research suggests that RiSE could lower stress levels and boost mental health by focusing on empowerment and developing a strong racial identity. Evidence also indicates that RiSE might lessen harmful physical reactions to stress, such as inflammation, which is linked to heart and metabolic diseases. Overall, the RiSE program appears promising in helping participants manage stress and improve their health.12678
Who Is on the Research Team?
Karen Saban, RN, PhD
Principal Investigator
Loyola University Chicago
Are You a Good Fit for This Trial?
This trial is for African American women aged 50-70, post-menopausal, who can read and speak English. They must have risk factors for heart or metabolic disease like high blood pressure, large waist circumference, high cholesterol, or Type 2 diabetes. Excluded are those on immune-altering meds, with recent dental issues, smokers within 3 months, active cancer/infection/substance abuse issues or significant cardiovascular history.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in either the RiSE or Health Education program, meeting online weekly for 8 consecutive weeks
Booster Sessions
Two booster sessions occur one month and two months after completion of the interventions
Follow-up
Participants are monitored for well-being, inflammation, and DNA methylation 6 months after the intervention
What Are the Treatments Tested in This Trial?
Interventions
- HEP
- RiSE
Find a Clinic Near You
Who Is Running the Clinical Trial?
Loyola University
Lead Sponsor
Columbia University
Collaborator